BIMINI Biotech
PrivateLast Round
Seed
Jan 8, 2025
Total Funding Raised
$3.89M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BIMINI Biotech operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Seed round in January 2025.
BIMINI Biotech is a preclinical stage biotechnology company developing novel first-in-class small molecule therapeutics for oncology with a focus on lymphomas and leukemia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIMINI Biotech Comparables
Compare BIMINI Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flindr Therapeutics | 76% | |
| Dimericon Therapeutics | 73% | |
| Solu Therapeutics | 69% |
For institutional investors. Book with your work email.
BIMINI Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2025 | ||||
| Seed | Jun 29, 2023 | ||||
| Seed | Oct 15, 2021 | ||||
| Pre Seed | Nov 26, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BIMINI Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Libertatis Ergo Holding | Seed |
| Torrey Pines Investment LLC | Seed |
| InnovationQuarter | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 133% MoM, reaching 2K.
- Aug 21, 2026
Monthly visitors grew 53% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 9, 2026
BIMINI Biotech BV hires Rachele Niccolai as its new scientist cell biologist to lead in-house cell biology activities, including cellular assay development and target and mechanism validation.
For institutional investors. Book with your work email.
BIMINI Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BIMINI Biotech's valuation, stock price, and market status.
Is BIMINI Biotech a public or private company?
BIMINI Biotech is a private company.
What is the current stock price of BIMINI Biotech?
BIMINI Biotech is a private company, so its shares have no public market price. Caplight tracks BIMINI Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BIMINI Biotech worth (valuation)?
Valuation information for BIMINI Biotech is not publicly available.
Can I buy BIMINI Biotech stock?
BIMINI Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BIMINI Biotech's last funding round?
BIMINI Biotech's most recent funding round was Seed on January 8, 2025.
Who are the main investors in BIMINI Biotech?
Key investors in BIMINI Biotech include Libertatis Ergo Holding, Torrey Pines Investment LLC, InnovationQuarter.
Will BIMINI Biotech IPO soon?
No public IPO plans have been announced for BIMINI Biotech.
How can I track BIMINI Biotech secondary market activity?
Caplight tracks bids, offers, and trades in BIMINI Biotech's shares on secondary markets.